4aa5
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | [[ | + | ==P38ALPHA MAP KINASE BOUND TO CMPD 33== |
+ | <StructureSection load='4aa5' size='340' side='right' caption='[[4aa5]], [[Resolution|resolution]] 2.38Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[4aa5]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AA5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AA5 FirstGlance]. <br> | ||
+ | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NQB:N-CYCLOPROPYL-4-METHYL-3-[6-(4-METHYLPIPERAZIN-1-YL)-4-OXIDANYLIDENE-QUINAZOLIN-3-YL]BENZAMIDE'>NQB</scene><br> | ||
+ | <tr><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSS:S-MERCAPTOCYSTEINE'>CSS</scene></td></tr> | ||
+ | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2baj|2baj]], [[1wfc|1wfc]], [[3zsi|3zsi]], [[1w7h|1w7h]], [[1wbo|1wbo]], [[1kv2|1kv2]], [[1yqj|1yqj]], [[1bmk|1bmk]], [[1bl7|1bl7]], [[1zyj|1zyj]], [[1a9u|1a9u]], [[1wbt|1wbt]], [[2i0h|2i0h]], [[3zs5|3zs5]], [[2yiw|2yiw]], [[2baq|2baq]], [[1wbv|1wbv]], [[1zz2|1zz2]], [[1di9|1di9]], [[1w83|1w83]], [[1bl6|1bl6]], [[1m7q|1m7q]], [[3zsh|3zsh]], [[1ian|1ian]], [[1oz1|1oz1]], [[1wbn|1wbn]], [[2bak|2bak]], [[3zya|3zya]], [[3zsg|3zsg]], [[2bal|2bal]], [[1wbs|1wbs]], [[1ouk|1ouk]], [[1ouy|1ouy]], [[2y8o|2y8o]], [[1r39|1r39]], [[2yis|2yis]], [[1kv1|1kv1]], [[1wbw|1wbw]], [[1w82|1w82]], [[2yix|2yix]], [[1r3c|1r3c]], [[1ove|1ove]], [[1w84|1w84]], [[1zzl|1zzl]], [[4aa0|4aa0]], [[4aa4|4aa4]], [[4aac|4aac]]</td></tr> | ||
+ | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4aa5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4aa5 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4aa5 RCSB], [http://www.ebi.ac.uk/pdbsum/4aa5 PDBsum]</span></td></tr> | ||
+ | <table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | A novel, potent and selective quinazolinone series of inhibitors of p38alpha MAP kinase has been identified. Modifications designed to address the issues of poor aqueous solubility and high plasma protein binding as well as embedded aniline functionalities resulted in the identification of a clinical candidate N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]ben zamide (AZD6703). Optimisation was guided by understanding of the binding modes from X-ray crystallographic studies which showed a switch from DFG 'out' to DFG 'in' as the inhibitor size was reduced to improve overall properties. | ||
- | + | The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]ben zamide (AZD6703), a clinical p38alpha MAP kinase inhibitor for the treatment of inflammatory diseases.,Brown DS, Cumming JG, Bethel P, Finlayson J, Gerhardt S, Nash I, Pauptit RA, Pike KG, Reid A, Snelson W, Swallow S, Thompson C Bioorg Med Chem Lett. 2012 Jun 15;22(12):3879-83. Epub 2012 May 2. PMID:22608965<ref>PMID:22608965</ref> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
+ | </div> | ||
- | + | ==See Also== | |
- | + | *[[Mitogen-activated protein kinase|Mitogen-activated protein kinase]] | |
- | + | == References == | |
- | + | <references/> | |
- | + | __TOC__ | |
- | + | </StructureSection> | |
- | + | ||
- | == | + | |
- | [[ | + | |
- | + | ||
- | == | + | |
- | < | + | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Gerhardt, S.]] | [[Category: Gerhardt, S.]] |
Revision as of 08:09, 5 June 2014
P38ALPHA MAP KINASE BOUND TO CMPD 33
|